Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Starting doses for tirzepatide are typically 2.5 mg per week, administered as a subcutaneous injection
The candidate has previously advanced through Phase IIa clinical evaluation in obese patients, as well as Phase I single ascending dose (SAD) studies in healthy volunteers and multiple ascending dose (MAD) studies in diabetic patients
, , ( ) ,
:max_bytes(150000):strip_icc():focal(986x146:988x148)/rebel-wilson-weight-loss-journey-split-061625-809e6ef637744d209748cedf32f34540.jpg)
It should be injected at least 5 centimetres (approximately two inches) away from the navel, avoiding the area directly around the belly button and the waistline where clothing may rub
Therefore, any claimed benefit is not guaranteed
US$ 21.30
US$ 21.88
US$ 29.40
US$ 26.19
